203 related articles for article (PubMed ID: 36293067)
1. A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest Risk.
Becker-Cohen M; Zimran A; Dinur T; Tiomkin M; Cozma C; Rolfs A; Arkadir D; Shulman E; Manor O; Paltiel O; Yahalom G; Berg D; Revel-Vilk S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293067
[TBL] [Abstract][Full Text] [Related]
2. Evolution of prodromal parkinsonian features in a cohort of
Avenali M; Toffoli M; Mullin S; McNeil A; Hughes DA; Mehta A; Blandini F; Schapira AHV
J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1091-1097. PubMed ID: 31221723
[TBL] [Abstract][Full Text] [Related]
3. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
Beavan M; McNeill A; Proukakis C; Hughes DA; Mehta A; Schapira AH
JAMA Neurol; 2015 Feb; 72(2):201-8. PubMed ID: 25506732
[TBL] [Abstract][Full Text] [Related]
4. Prodromal substantia nigra sonography undermines suggested association between substrate accumulation and the risk for GBA-related Parkinson's disease.
Arkadir D; Dinur T; Becker Cohen M; Revel-Vilk S; Tiomkin M; Brüggemann N; Cozma C; Rolfs A; Zimran A
Eur J Neurol; 2019 Jul; 26(7):1013-1018. PubMed ID: 30714262
[TBL] [Abstract][Full Text] [Related]
5. The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher disease.
Higgins AL; Toffoli M; Mullin S; Lee CY; Koletsi S; Avenali M; Blandini F; Schapira AH
Neurodegener Dis Manag; 2021 Dec; 11(6):451-458. PubMed ID: 34666501
[TBL] [Abstract][Full Text] [Related]
6. Evolution and clustering of prodromal parkinsonian features in GBA1 carriers.
Mullin S; Beavan M; Bestwick J; McNeill A; Proukakis C; Cox T; Hughes D; Mehta A; Zetterberg H; Schapira AHV
Mov Disord; 2019 Sep; 34(9):1365-1373. PubMed ID: 31251436
[TBL] [Abstract][Full Text] [Related]
7. Features of
Malek N; Weil RS; Bresner C; Lawton MA; Grosset KA; Tan M; Bajaj N; Barker RA; Burn DJ; Foltynie T; Hardy J; Wood NW; Ben-Shlomo Y; Williams NW; Grosset DG; Morris HR;
J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):702-709. PubMed ID: 29378790
[TBL] [Abstract][Full Text] [Related]
8. Prodromal Clinical Markers of Parkinson disease in Gaucher Disease Individuals.
Gatto EM; Etcheverry JL; Sanguinetti A; Cesarini M; Fernandez Escobar N; Drelichman G
Eur Neurol; 2016; 76(1-2):19-21. PubMed ID: 27344356
[TBL] [Abstract][Full Text] [Related]
9. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
Toffoli M; Chohan H; Mullin S; Jesuthasan A; Yalkic S; Koletsi S; Menozzi E; Rahall S; Limbachiya N; Loefflad N; Higgins A; Bestwick J; Lucas-Del-Pozo S; Fierli F; Farbos A; Mezabrovschi R; Lee-Yin C; Schrag A; Moreno-Martinez D; Hughes D; Noyce A; Colclough K; Jeffries AR; Proukakis C; Schapira AHV
Neurobiol Dis; 2023 Nov; 188():106343. PubMed ID: 37926171
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.
Alcalay RN; Dinur T; Quinn T; Sakanaka K; Levy O; Waters C; Fahn S; Dorovski T; Chung WK; Pauciulo M; Nichols W; Rana HQ; Balwani M; Bier L; Elstein D; Zimran A
JAMA Neurol; 2014 Jun; 71(6):752-7. PubMed ID: 24756352
[TBL] [Abstract][Full Text] [Related]
12. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.
Thaler A; Bregman N; Gurevich T; Shiner T; Dror Y; Zmira O; Gan-Or Z; Bar-Shira A; Gana-Weisz M; Orr-Urtreger A; Giladi N; Mirelman A
Parkinsonism Relat Disord; 2018 Oct; 55():45-49. PubMed ID: 29784561
[TBL] [Abstract][Full Text] [Related]
14. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
[TBL] [Abstract][Full Text] [Related]
15. Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling.
Rana HQ; Balwani M; Bier L; Alcalay RN
Genet Med; 2013 Feb; 15(2):146-9. PubMed ID: 22935721
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's Clustering in Families of Non-Neuronopathic N370S GBA Mutation Carriers Indicates the Presence of Genetic Modifiers.
Dinur T; Becker-Cohen M; Revel-Vilk S; Zimran A; Arkadir D
J Parkinsons Dis; 2021; 11(2):615-618. PubMed ID: 33612495
[TBL] [Abstract][Full Text] [Related]
17. Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.
Saunders-Pullman R; Hagenah J; Dhawan V; Stanley K; Pastores G; Sathe S; Tagliati M; Condefer K; Palmese C; Brüggemann N; Klein C; Roe A; Kornreich R; Ozelius L; Bressman S
Mov Disord; 2010 Jul; 25(10):1364-72. PubMed ID: 20629126
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the frequency of non-motor symptoms of Parkinson's disease in adult patients with Gaucher disease type 1.
Wilke MVMB; Dornelles AD; Schuh AS; Vairo FP; Basgalupp SP; Siebert M; Nalin T; Piltcher OB; Schwartz IVD
Orphanet J Rare Dis; 2019 May; 14(1):103. PubMed ID: 31077260
[TBL] [Abstract][Full Text] [Related]
19. Patient's perception: shorter and more severe prodromal phase in GBA-associated PD.
Zimmermann M; Gaenslen A; Prahl K; Srulijes K; Hauser AK; Schulte C; Csoti I; Berg D; Brockmann K
Eur J Neurol; 2019 Apr; 26(4):694-698. PubMed ID: 30107068
[TBL] [Abstract][Full Text] [Related]
20. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.
Davis MY; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Goldman JG; Stebbins GT; Bernard B; Wszolek ZK; Ross OA; Dickson DW; Eidelberg D; Mattis PJ; Niethammer M; Yearout D; Hu SC; Cholerton BA; Smith M; Mata IF; Montine TJ; Edwards KL; Zabetian CP
JAMA Neurol; 2016 Oct; 73(10):1217-1224. PubMed ID: 27571329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
